Clinical Trials Directory

Trials / Sponsors / Cellid Co., Ltd.

Cellid Co., Ltd.

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects with HPV Positive HNSCC.
Head and Neck Squamous Cell Carcinoma (HNSCC), HPV (human Papillomavirus)-Associated Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma
Phase 1 / Phase 22025-03-01
Active Not RecruitingImmunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Voluntee
COVID-19, Vaccines
Phase 32023-11-27
CompletedSafety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine
COVID-19, Vaccines
Phase 1 / Phase 22022-09-14
TerminatedSafety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1
COVID-19, Vaccines
Phase 22022-08-19
CompletedSafety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
Covid19
Phase 12021-09-09
CompletedSafety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers
COVID-19
Phase 1 / Phase 22020-12-29
CompletedSafety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Re
Stomach Neoplasms
Phase 12018-02-26
CompletedSafety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer
Uterine Cervical Neoplasms
Phase 1 / Phase 22016-10-01